Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2500${count})

  • Therapeutic Pipeline Program, 2020
    Photoreceptor-Directed Light Therapy in Parkinson’s Disease

    Study Rationale:    
    Non-motor symptoms including sleep disturbances are common and enormously impact quality of life in people with Parkinson’s disease (PD). Sleep disruption affects motor function...

  • Research Grant Supplement, 2020
    Discovery of Selective PET Imaging Agents for Tauopathies and Alpha-Synuclein

    Study Rationale:    
    The development of alpha-synuclein and tau imaging agents will be valuable for people with Parkinson’s disease and Frontal Temporal Dementia (FTD), as deposits of these proteins...

  • Research Grant, 2020
    Parkinson’s Disease Subtyping by Genetic and Intestinal Inflammation Biomarkers

    Study Rationale: 
    Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide. Currently, no drugs are available to treat or prevent the disease because the processes...

  • Biosample Use Program, 2020
    Adaptive Immune Markers for Predicting Cognitive Decline in Parkinson’s Disease

    Study Rationale:    
    For reasons not well understood, people with Parkinson's disease are at risk for developing dementia, a decline in memory, thinking and/or language abilities severe enough to...

  • Research Grant, 2020
    Investigating the Role of LRRK2 in Tau Pathogenesis

    Study Rationale:
    While most cases of Parkinson’s disease have no known genetic cause, a subset of Parkinson’s is caused by mutations in the leucine-rich repeat kinase 2 (LRRK2) gene. It is believed...

  • Research Grant Supplement, 2020
    Measuring LRRK2-Mediated Rab Protein in Parkinson’s Disease

    Study Rationale: 
    The discovery of LRRK2 (Leucine rich repeat kinase 2) recently as a gene that causes Parkinson’s disease has provided considerable insights into the development of both familial and...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.